Subsequently, these tumor cells are reprogrammed into in situ cytokine factories that continuously secrete XCL1 and FLT3L, which effectively recruit and differentiate cDC1s within the tumor microenvironment. The gene discussed is FLT3LG; the disease is neoplasm.